immune modulation is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Stoney River Steakhouse & Grill is a chain of steakhouses in the United States. In 2008, the company had 12 locations. As of 2025, there are ten Stoney River restaurants. In 2007, O'Charley's filed a lawsuit against competitor Darden claiming their Rocky River Grillhouse restaurant was too similar of a trademark to their Stoney River Legendary Steaks brand.
==== Inflammation ==== When particular GPCRs are activated by their specific chemokines Gβγ directly activates PI3Kγ which is involved in the recruitment of neutrophils that contribute to inflammation. It has been discovered that the inhibition of PI3Kγ significantly reduces inflammation. PI3Kγ is the intended target molecule in the prevention of inflammation as it is the common signalling effector of many different chemokine and receptor types involved in promoting inflammation. Although PI3Kγ is the intended target there are other isoforms of PI3 which perform different functions from PI3Kγ. Since PI3Kγ is specifically regulated by Gβγ, while other isoforms of PI3 are largely regulated by other molecules, inhibiting Gβγ signalling would provide the desired specificity of a therapeutic agent designed to treat inflammation.
Dorothy Hodgkin on Nobelprize.org including the Nobel Lecture, 11 December 1964 The X-ray Analysis of Complicated Molecules Portraits of Dorothy Hodgkin at the National Portrait Gallery, London Works by or about Dorothy Hodgkin at the Internet Archive Four interviews with Dorothy Crowfoot Hodgkin recorded between 1987 and 1989 in partnership with the Royal College of Physicians are held in the Medical Sciences Video Archive in the Special Collections at Oxford Brookes University: Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Sir Gordon Wolstenholme: Interview 1 (1987). Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Max Blythe: Interview 2 (1988). Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Max Blythe: Interview 3 (1989). Professor Dorothy Crowfoot Hodgkin OM FRS at home talking with Max Blythe: Interview 4 (1989). Watch a lecture of Dorothy Crowfoot Hodgkin (1910–1994) at the 1988 Nobel Laureates Symposium at the annual meeting of the American Crystallographic Association, Philadelphia Dorothy Hodgkin featured on the BBC Radio 4 program In Our Time on 3 October 2019. "The exceptional life of Dorothy Crowfoot Hodgkin", BBC "Ideas" video, 27 September 2021
82nd Airborne Division Division Headquarters 325th Glider Infantry Regiment (325th GIR) (received the 2nd Battalion, 401st GIR, 101st Airborne Division on 1 March 1945, which became the 3rd Battalion, 325th GIR) Headquarters and Headquarters Company 2× glider infantry battalions (3× glider infantry battalions from 1 March 1945) each battalion consists of: 1× Headquarters and Headquarters Company, 3× Rifle companies Anti-Tank Company (assigned 1 March 1945) Service Company 504th Parachute Infantry Regiment (504th PIR) Headquarters and Headquarters Company 3× parachute infantry battalions each battalion consists of: 1× Headquarters and Headquarters Company, 3× Rifle companies Service Company 505th Parachute Infantry Regiment (505th PIR) same organization as 504th Parachute Infantry Regiment 82nd Airborne Division Artillery Headquarters Battery 319th Glider Field Artillery Battalion Headquarters and Headquarters and Service Battery 2× Batteries (M1 75mm pack howitzers) 320th Glider Field Artillery Battalion same organization as 319th Glider Field Artillery Battalion 376th Parachute Field Artillery Battalion Headquarters and Headquarters and Service Battery 3× Batteries (M1 75mm pack howitzers) Anti-Aircraft and Anti-Tank Battery (M2 .50-caliber machine guns, M3 37mm Anti-Tank guns, and M1 Bazookas) 456th Parachute Field Artillery Battalion same organization as 376th Parachute Field Artillery Battalion Special Troops (Headquarters activated 1 March 45, until then the units below were directly under the Division Headquarters) Headquarters Company, 82nd Airborne Division 82nd Airborne Signal Company 407th Airborne Quartermaster Company 782nd Airborne Ordnance Company Reconnaissance Platoon (assigned 1 March 45) Military Police Platoon Band (assigned 1 March 45) 80th Airborne Anti-Aircraft Artillery Battalion Headquarters and Headquarters Detachment 3× Automatic weapon batteries (M3 37mm Anti-Tank guns and from June 1944 M1 57mm anti-tank guns) 3× Machine gun batteries (M2 .50-caliber machine guns) 307th Airborne Engineer Battalion Headquarters and Headquarters and Service Company 2× Glider engineer companies 1× Parachute engineer company 82nd Parachute Maintenance Company (provisional unit made permanent on 1 March 1945) 307th Airborne Medical Company Attached paratrooper units:
A refrigeration system meant to cool tanks containing liquid MIC had been shut down in January 1982 and the freon had been removed in June 1984. Since the MIC storage system assumed refrigeration, its high temperature alarm, set to sound at 11 °C (52 °F) had long since been disconnected, and tank storage temperatures ranged between 15 °C (59 °F) and 40 °C (104 °F) A flare tower to burn the MIC gas as it escaped, which had had a connecting pipe removed for maintenance, was improperly sized to neutralise a leak of the size produced by tank E610. A vent gas scrubber which had been deactivated at the time and was in 'standby' mode, and similarly had insufficient caustic soda and power to safely stop a leak of the magnitude produced. About 30 tonnes of MIC escaped from the tank into the atmosphere in 45 to 60 minutes. This would increase to 40 tonnes within two hours. The gases were blown in a southeast direction over Bhopal. A UCIL employee triggered the plant's alarm system at 12:50 a.m. as the concentration of gas in and around the plant became difficult to tolerate. Activation of the system triggered two siren alarms: one that specifically sounded inside the UCIL plant itself and a second directed to the exterior which would alert the general public and the city of Bhopal. The two siren systems had been decoupled from one another in 1982, so that it was possible to leave the factory warning siren on while the public one remained inactive. This is what had occurred; the public siren briefly sounded at 12:50 a.m.
Sources: en.wikipedia.org
== Biodiversity of proteases == Proteases occur in all organisms, from prokaryotes to eukaryotes to viruses. These enzymes are involved in a multitude of physiological reactions from simple digestion of food proteins to highly regulated cascades (e.g., the blood-clotting cascade, the complement system, apoptosis pathways, and the invertebrate prophenoloxidase-activating cascade). Proteases can either break specific peptide bonds (limited proteolysis), depending on the amino acid sequence of a protein, or completely break down a peptide to amino acids (unlimited proteolysis). The activity can be a destructive change (abolishing a protein's function or digesting it to its principal components), it can be an activation of a function, or it can be a signal in a signalling pathway.
Dolichonychia is a medical condition in which the nail beds of the fingers and toes are abnormally long and slender, specifically, a finger nail index of 1.30 or more, it is a common feature in people with connective tissue disorders, such as Ehlers–Danlos syndromes, Marfan syndrome, and hypohidrotic ectodermal dysplasia., it often appears alongside arachnodactyly and/or dolichostenomelia, which is the condition of having long and slender fingers and toes.
== Beverages == Tea (chai) and coffee (kawa) are popular beverages and important cash crops. These can be served English-style or spiced (chai masala). Coca-Cola, Pepsi and Fanta have all made inroads in the Ugandan market and soft drinks have become very popular. Both traditional and Western beers are probably the most widely available alcoholic beverages across Uganda.
=== Others === Jessamine Lovelace — the ghost guardian of the London Institute. Also known as Jessamine Gray after her secret marriage to Tessa's brother Nate in The Infernal Devices. Jesse Blackthorn — Tatiana's deceased son and Grace Blackthorn's adoptive brother. His spirit can only be seen by his mother, Grace, and Lucie.
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.